D-156-2013 Class III Terminated

Recalled by Bayer HealthCare Pharmaceuticals Inc. — Lynnwood, WA

FDA drug recall D-156-2013 was initiated by Bayer HealthCare Pharmaceuticals Inc. on May 31, 2012 and is designated Class III. Reason for recall: Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point. The recall status is terminated (terminated May 10, 2013). Affected quantity: 138,505 vials.

Recall details

Product Type
Drugs
Report Date
Feb 13, 2013
Initiation Date
May 31, 2012
Termination Date
May 10, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
138,505 vials

Product description

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Reason for recall

Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.

Distribution pattern

Nationwide

Code information

B18511 Exp. 04/12 , B18513 Exp. 05/12, B18515 Exp. 06/12, B18517 Exp. 06/12, B18825 Exp. 10/12, B18831 Exp.12/12

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-156-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-156-2013. Report a data issue: hello@regdatalab.com.